Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Deletion of the retinoblastoma gene in multiple myeloma.

Dao DD, Sawyer JR, Epstein J, Hoover RG, Barlogie B, Tricot G.

Leukemia. 1994 Aug;8(8):1280-4.

PMID:
8057662
2.

The retinoblastoma gene (RB-1) status in multiple myeloma: a report on 35 cases.

Zandecki M, Facon T, Preudhomme C, Vanrumbeke M, Vachee A, Quesnel B, Lai JL, Cosson A, Fenaux P.

Leuk Lymphoma. 1995 Aug;18(5-6):497-503.

PMID:
8528059
3.

The retinoblastoma susceptibility gene RB-1 in multiple myeloma.

Juge-Morineau N, Harousseau JL, Amiot M, Bataille R.

Leuk Lymphoma. 1997 Jan;24(3-4):229-37. Review.

PMID:
9156653
4.

Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma.

Kaufmann H, Krömer E, Nösslinger T, Weltermann A, Ackermann J, Reisner R, Bernhart M, Drach J.

Eur J Haematol. 2003 Sep;71(3):179-83.

PMID:
12930318
5.

Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization.

Zojer N, Königsberg R, Ackermann J, Fritz E, Dallinger S, Krömer E, Kaufmann H, Riedl L, Gisslinger H, Schreiber S, Heinz R, Ludwig H, Huber H, Drach J.

Blood. 2000 Mar 15;95(6):1925-30.

6.

Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.

Tabernero D, San Miguel JF, Garcia-Sanz M, Nájera L, García-Isidoro M, Peréz-Simon JA, Gonzalez M, Wiegant J, Raap AK, Orfão A.

Am J Pathol. 1996 Jul;149(1):153-61.

7.

Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes.

Pérez-Simón JA, García-Sanz R, Tabernero MD, Almeida J, González M, Fernández-Calvo J, Moro MJ, Hernández JM, San Miguel JF, Orfão A.

Blood. 1998 May 1;91(9):3366-71.

8.

Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.

Fonseca R, Oken MM, Harrington D, Bailey RJ, Van Wier SA, Henderson KJ, Kay NE, Van Ness B, Greipp PR, Dewald GW.

Leukemia. 2001 Jun;15(6):981-6.

PMID:
11417487
9.

Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.

Harrison CJ, Mazzullo H, Cheung KL, Gerrard G, Jalali GR, Mehta A, Osier DG, Orchard KH.

Br J Haematol. 2003 Mar;120(6):944-52.

PMID:
12648063
10.

The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.

Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M.

Blood. 1997 Jul 15;90(2):526-34.

11.

Identification of 13q deletion, trisomy 1q, and IgH rearrangement as the most frequent chromosomal changes found in Korean patients with multiple myeloma.

Bang SM, Kim YR, Cho HI, Chi HS, Seo EJ, Park CJ, Yoo SJ, Kim HC, Chun HG, Min HC, Oh BR, Kim TY, Lee JH, Lee DS.

Cancer Genet Cytogenet. 2006 Jul 15;168(2):124-32.

PMID:
16843102
13.

Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization.

Chang H, Bouman D, Boerkoel CF, Stewart AK, Squire JA.

Leukemia. 1999 Jan;13(1):105-9.

PMID:
10049044
14.

Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.

Chen L, Li J, Xu W, Qiu H, Zhu Y, Zhang Y, Duan L, Qian S, Lu H.

Exp Oncol. 2007 Jun;29(2):116-20.

PMID:
17704743
15.

Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.

Rasillo A, Tabernero MD, Sánchez ML, Pérez de Andrés M, Martín Ayuso M, Hernández J, Moro MJ, Fernández-Calvo J, Sayagués JM, Bortoluci A, San Miguel JF, Orfao A.

Cancer. 2003 Feb 1;97(3):601-9.

16.

[Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].

Lee JW, Lee JK, Hong YJ, Hong SI, Chang YH.

Korean J Lab Med. 2008 Dec;28(6):413-8. doi: 10.3343/kjlm.2008.28.6.413. Korean.

17.

Effect of 13q deletion on IL-6 production in patients with multiple myeloma: a hypothesis may hold true.

Neemat K, Rania K, Tarek M, Hamdy AA.

Clin Lab. 2014;60(8):1393-9.

PMID:
25185427
18.

[Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].

Liu SY, Huang JW, Zhang J, Du HP, Jiang H, Li JY, Xue YQ.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Dec;24(6):685-8. Chinese.

PMID:
18067084
19.

Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.

Krämer A, Schultheis B, Bergmann J, Willer A, Hegenbart U, Ho AD, Goldschmidt H, Hehlmann R.

Leukemia. 2002 Sep;16(9):1844-51.

20.

Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.

Zojer N, Schuster-Kolbe J, Assmann I, Ackermann J, Strasser K, Hübl W, Drach J, Ludwig H.

Br J Haematol. 2002 Jun;117(4):852-9.

PMID:
12060120

Supplemental Content

Support Center